EW analyst estimates

Edwards Lifesciences (EW) analyst ratings, the average price target and its range, and every firm's latest call.

EW analyst ratings and price targets

DateFirmCallTarget
Nov 20, 2026RBC CapitalRBC Capital on Edwards Lifesciences (EW): 'Top-Tier Large Cap MedTech Growth Expected to Continue in 2027'$115.00
Nov 5, 2026Mizuho SecuritiesEdwards Lifesciences (EW) PT Raised to $120 at Mizuho$120.00
Nov 5, 2026Wells FargoEdwards Lifesciences (EW) PT Raised to $113 at Wells Fargo$113.00
Nov 5, 2026Truist FinancialEdwards Lifesciences (EW) PT Raised to $118 at Truist Securities$118.00
Nov 4, 2026Truist FinancialTruist Securities Upgrades Edwards Lifesciences (EW) to Buy$113.00
Oct 27, 2026Deutsche BankTD Cowen Reiterates Buy Rating on Edwards Lifesciences (EW)$104.00
Jul 28, 2026UBSEdwards Lifesciences upgraded to Buy from Neutral at UBS$110.00
Jul 24, 2026Leerink PartnersEdwards Lifesciences upgraded to Outperform from Market Perform at Leerink$101.00
Jul 24, 2026Piper SandlerEdwards Lifesciences price target raised to $101 from $100 at Piper Sandler$101.00
Jul 16, 2026Truist FinancialEdwards Lifesciences price target raised to $95 from $90 at Truist$95.00
Jul 13, 2026RBC CapitalEdwards Lifesciences price target raised to $110 from $100 at RBC Capital$110.00
Jul 6, 2026Evercore ISIEdwards Lifesciences price target raised to $100 from $93 at Evercore ISI$100.00
Jun 30, 2026BTIGEdwards Lifesciences price target raised to $110 from $100 at BTIG$110.00
Apr 27, 2026BarclaysEdwards Lifesciences price target raised to $110 from $104 at Barclays$110.00
Apr 24, 2026Truist FinancialEdwards Lifesciences price target raised to $90 from $89 at Truist$90.00